Retinal angiomatous proliferation in age-related macular degeneration.
about
Idiopathic juxtafoveolar retinal telangiectasis: a current reviewTherapeutic targets in age-related macular diseaseOverlay of conventional angiographic and en-face OCT images enhances their interpretation.Regulation of signaling events involved in the pathophysiology of neovascular AMDResistance to antivascular endothelial growth factor treatment in age-related macular degenerationCol4a1 mutations cause progressive retinal neovascular defects and retinopathyCharacterization of a spontaneous retinal neovascular mouse modelAssociation of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual PrognosisAdeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularizationOne-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.Imaging polarimetry in patients with neovascular age-related macular degeneration.Semaphorin 3F forms an anti-angiogenic barrier in outer retina.Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouseShort-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.Characteristics of age-related macular degeneration in patients with diabetic retinopathy.Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments TrialsTargeting VE-PTP activates TIE2 and stabilizes the ocular vasculatureAnalysis of candidate genes for macular telangiectasia type 2Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.Successful treatment of retinal angiomatous proliferation with intravitreal triamcinolone and ranibizumab injections in a 67-year-old male.Clinical characteristics and current treatment of age-related macular degeneration.Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degenerationInterleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.The role of Vldlr in intraretinal angiogenesis in mice.Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse.En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation).Can retinal microtrauma by internal limiting membrane peeling cause retinal angiomatosis proliferans?The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration.The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages.Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration
P2860
Q24616761-D2BE7B36-C488-45B3-AE94-0F6D5BC7E24DQ24623107-06784546-E72E-4ED7-9871-E153F38BF184Q24814369-6B45381A-0498-49F2-97D9-AA31C4DC49FCQ26751293-4B7DE597-4430-4500-9881-F80F1B0F0E07Q27015781-8FF36E16-48C1-4C67-B519-C86842C47581Q27303061-BD0911F3-F109-4403-BC33-75928ACAA35BQ27312714-F4ABCD62-4864-4845-9B24-FD6916DF4139Q30240011-B82E161B-D08E-4655-892C-62876CDFAC4BQ30438969-DEA7B769-6D82-4FA7-98AB-DCC1DE523EE8Q30490589-5CDA26DD-2A49-4E32-A8B8-5EA13955E15AQ31081886-3AC61947-EF5B-4B1E-92CF-F625BA72576FQ31092005-843FFF5C-2494-406A-95FB-957B3D843A41Q33216197-49CD9DE4-8E67-40B5-828D-BF4DD3F68739Q33252655-EA2AB50F-3710-4995-A7B1-D737C326A2B0Q33257622-551C5563-5516-46CD-A629-7B5E35EE9689Q33281889-798A046E-5791-4549-8AE8-34F1D36084D2Q33593419-9DFFF557-339E-4F23-989E-766ADADCC65FQ33833925-ABF3433F-21B2-4498-8116-27B388545C15Q33846379-21D6EDBC-523D-44C0-AB8C-BA00E2869591Q33886005-F58F8FC2-DCF6-40BB-A247-403E19BE7565Q33888124-67DA5C7E-5EBF-4307-A650-A64AA602545FQ33984698-F5F6E551-35C2-4074-AE7A-467B72D1C409Q34237495-1EC60168-B4F3-44F0-942F-A9A85694A432Q34311551-D576D9AE-D18D-47A5-8E1D-6D2CF7E300ADQ34410734-CC5954A1-ED18-42F6-A91B-5C36F43B07FBQ34678965-CF4C0347-CD9E-4DE6-AA1B-8CBFDFC547B7Q34792152-460FA3A4-F249-4198-B666-C16CFFD7A1BCQ34930298-48B3D55E-D48B-4A68-9DE6-18549D3FF6D4Q35024891-853A6876-0439-4B76-8EEB-562FE4BC505CQ35179686-69BC8620-5FA6-453D-981F-C52E2B71AB69Q35191520-9A43FAE0-FEF3-4DA4-9249-168DADEF7953Q35221259-7DC15F61-77B1-42DE-B9A2-5AB5C95C9D2BQ35566342-3B1EB605-8CF5-4313-9115-E034FFB121B5Q35599056-79ED87AA-5404-4595-8831-05366223A0F6Q35686271-FBE510AC-57A0-4FBE-9402-59EF1FFB75F4Q35691953-B8368AB2-56FC-483C-88A6-A15CB7DDAA3EQ35807878-C14A2A47-7469-4B6B-8407-6F633BB279DFQ35872677-D6C57DF7-3540-46D1-B940-21153315F19AQ35874689-55110C5B-1F66-418A-B591-DF9547F50BFAQ35902212-1AEB6B44-8B8E-43D2-807E-BFE9B19C8E40
P2860
Retinal angiomatous proliferation in age-related macular degeneration.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Retinal angiomatous proliferation in age-related macular degeneration.
@ast
Retinal angiomatous proliferation in age-related macular degeneration.
@en
Retinal angiomatous proliferation in age-related macular degeneration.
@nl
type
label
Retinal angiomatous proliferation in age-related macular degeneration.
@ast
Retinal angiomatous proliferation in age-related macular degeneration.
@en
Retinal angiomatous proliferation in age-related macular degeneration.
@nl
prefLabel
Retinal angiomatous proliferation in age-related macular degeneration.
@ast
Retinal angiomatous proliferation in age-related macular degeneration.
@en
Retinal angiomatous proliferation in age-related macular degeneration.
@nl
P2093
P1433
P1476
Retinal angiomatous proliferation in age-related macular degeneration.
@en
P2093
Borodoker N
Carvalho C
Rodriguez-Coleman H
Sorenson J
Yannuzzi LA
P304
P356
10.1097/00006982-200110000-00003
P577
2001-01-01T00:00:00Z